Immix Biopharma, Inc. ( IMMX) - Stock Earnings
IMMX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
IMMX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -10.7 million USD | — USD |
| 2026Q1 | -10.1 million USD | — USD |
| 2026Q2 | -11.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IMMX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.4 million USD | — USD |
| 2024 | -21.6 million USD | — USD |
| 2025 | -29.4 million USD | — USD |
| 2026 Est. | — | — |
IMMX
Price: $7.98
52 week price:
Earnings Per Share: -0.98 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 12035
Market Capitalization: 551.1 million